FDA Inspection
BE Pharmaceuticals Private Ltd.BE Pharmaceuticals Private Ltd. – FDA Inspection, Jul 7, 2023
Record Details
This FDA Inspection record concerns BE Pharmaceuticals Private Ltd., with an inspection on July 7, 2023, covering drugs.
- Inspection Date
- July 7, 2023
- Product Type
- Drugs
View Company Profile
ID · 4dce4493-9aed-4689-b70f-7f27dba1c1ff
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1209633
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.113(b)Procedures for sterile drug products
- 21 CFR 211.160(a)Deviations from laboratory control requirements
- 21 CFR 211.192Investigations of discrepancies, failures
- 21 CFR 211.194(a)(2)Laboratory Test Method Verification
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.42(c)(10)(v)Cleaning System
- 21 CFR 211.84(d)(2)Component written specification
Full citation text and observation details available on the Dashboard.
Other FDA inspections of BE Pharmaceuticals Private Ltd.
1| Date | Classification | Office | Project area |
|---|---|---|---|
| June 12, 2014 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for BE Pharmaceuticals Private Ltd.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.